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Methodology   
 
First search of books, official websites, and Pubmed database reviews to get the basic 
principles. After that, Pubmed database original articles and important reviews were selected 
based on the journal impact and the date of publication. 
ASD biomarkers 
 
 Hyperserotonemia. 
 Immune system dysfunction. 
 Decreased GABA receptor  Increased ratio of excitation to inhibition. 
 Abnormal rate of symmetric brain growth. 
 Altered brain region size (amygdale, striatal nucleus). 
 Mitochondrial dysfunction.  
 Structural abnormalities in the “social brain”: 
 
 
 
 
 
 
 
 
 
 
 
Physiopathology  
 
 Neurobiological basis of  ASD: altered patterns of neural connectivity  reduced long-range 
functional connectivity in the cortex and enhanced local connectivity in multiple brain regions. 
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 Principal genes associated with high for ASD (susceptibility genes):   
Figure 1. ASD main characteristics (Adapted from 
http://parentinghealthybabies.com/autism-spectrum-
discorder-asd-in-children/). 
 
Figure 2. Areas of the “social brain” (Adapted from Gotts et al., 2012) 
  
 Environmental factors examples: pesticides, air pollution, drugs, paternal age, 
maternal nutritional status, etc.  
 
Current treatment  
 
 The principal treatments for ASD now a days, are based on behavioral interventions  ABA. 
 A wide variety of potential interventions for ASD have been championed, but few have been 
subjected to the rigors of controlled clinical trials.  
 Data shows all this available treatments for ASDs have an inconsistent efficacy. 
 
 
Introduction 
 
 Leo Kanner in 1943 identifies four main characteristics of Autism: 
 Inability to relate well with people. 
 Serious difficulties in communication and language development. 
 Persistent insistence on sameness. 
 Early onset of the disorder, which is evident in the first three years of life. 
 
 According to DMS-V, ASD is a group of 4 developmental disorders with symptoms that are 
seen on a continuum ranging from mild to severe expression.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Heterogeneous as notable for its variability as for its features.   
 Thirty years ago autism was very rare (4 of 10.000) but today ASD prevalence range is at 
about 0.6%-0.8% in preschool children and 1% in school children and adults. 
Objectives 
 
 Provide an overview of the main characteristics of ASD. 
 Emphasize in the genetic alterations and their pathways related to ASD fisiopathology.  
Etiology 
 
 ASD is a complex human genetic disorder that involves interactions 
between genes and environment: 
Figure 3. Complexity of gene and 
environment interactions in ASD 
(Adapted from Schwartzer et al., 
2012) 
  
Table 1. Genes associated with ASD (Adapted from Toro et al., 2010). 
Genes Chromosome Function Evidence 
FMR1 Xq27 Synaptic translation Mutations 
MECP2  Xq26 Chromatin remodeling CNV, mutations 
TSC1  9q24.13 mTOR/PI3K pathway CNV, mutations 
TSC2 16p13.3 mTOR/PI3K pathway CNV, mutations 
NF1 17q11.2 mTOR/PI3K pathway CNV, mutations 
PTEN 10q23.31 mTOR/PI3K pathway CNV, mutations 
RFWD2 1q25.2-q25.2 Ubiquitination CNV 
NRXN1 2p16.3 Synaptic CAM CNV, mutations, SNP 
CNTN4 3p26.3 Synaptic CAM CNV 
MEF2C 5q14.3 Transcription factor CNV, mutations 
SYNGAP1 6p21.3 Synaptic Ras GAP CNV 
CNTNAP2 7q35-7q36.1 Synaptic CAM CNV, rare variantsa 
UBE3A 15q11-q13 Ubiquitination CNV 
SHANK3 22q13 Synaptic scaffold CNV, mutations 
NLGN3 Xq13.1 Synaptic CAM Mutation 
NLGN4 Xp22 Synaptic CAM CNV, mutations 
GRIA3 Xp25 Synaptic receptor CNV 
SEMA5A 5p15.2 Axonal guidance  SNP 
MET 7q31.2 Tyrosin kinase SNP 
PARK2 6q26 Ubiquitination CNV 
FBXO40 3q13.3  Unknown function CNV 
Figure 4. Potential effects of network connectivity 
patterns on brain activation (Adapted from Belmonte et 
al., 2004).  
  
Figure 5. Steps for the generation of new (cortical) neurons (Adapted from 
Maurer et al., 2012).   
  
 Changes in ASD connectivity could be due to:  
1. Dendrite spine growth 2. Synapse formation and stabilization  
Figure 6. Lifetime trajectory of dendritic spine number in 
ASD (pink) (Adapted from Penzes et al., 2011).  
 Figure 7. The potential relationship of ASD genes to synaptic 
function. (Adapted from Walsh, 2008).   
 
2.2. mTOR/PI3K pathway  TSC1/TSC2, NF1 and PTEN  2.3. Ubiquitination  UBE3A 
2.4. Abnormal level of transcription regulatory proteins 
  MECP2 and FMR1  
 
2.1. Synaptic adhesion proteins     
Figure 8. The MET and mTOR/PI3K pathway, and genes 
implicated in ASD risk (Adapted from Kelleher and Bear, 
2008).   
 
Figure 9. UBEA, Arc, 
and AMPAR 
endocytosis and 
UBE3A  mutation 
causing ASD 
(Adapted from Tai 
and Shuman, 2010) .   
 
Conclusions  
 
 Impaired neuronal network connectivity strongly indicates the basis of 
behavioral and cognitive abnormalities in ASD.  
 It is clear that ASD has a strong genetic component.  
 None of the current treatments are based upon a specific understanding of the 
causes of ASD.  
 
 FUTURE CHALLENGE: determine the signaling pathways in which disease 
risk genes function, in order to translate this knowledge into mechanism-
based therapeutics.  
 
